Summary

Other Scenarios:

Buyer: King Pharmaceuticals (KG) Last Price: 16.20 Market Cap.: 3.94B
Target: Andrx Corporation (ADRX) Last Price: 25.00 Market Cap.: 1.85B

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
*Healthcare 872
Biopharmaceuticals 329
Healthcare Services   158
Medical Devices   246
Nutritional Health   22
Outsourced Services 66

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 68)
  • Adrenalin Chloride Solution (Epinephrine)
  • Corgard (Nadolol)
  • Adenocard (Adenosine)
  • Procanbid (Procainamide Hydrochloride)
Target (Total: 67)
  • Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet
  • Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate
  • Andrx Pharmaceuticals Loratadine/Pseudoephedrine Extended Release
  • Andrx Pharmaceuticals Metoprolol Succinate
Buyer
  • Meridian Medical Technologies Prime ECG Electrocardiac Mapping System
  • Binodenoson
  • Meridian Medical Technologies Transtelephonic Blood Pressure Monitors
  • Meridian Medical Technologies CardioBeepers
Target
  • Anda, Inc.
  • Value In Pharmaceuticals (VIP)/Valmed Pharmaceuticals
  • Andrx Corp.
  • Armstrong Pharmaceuticals, Inc.

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 4)
  • sanofi-aventis (ADR) (SNY)
  • Palatin Technologies, Inc. (PTN)
  • DepoMed, Inc. (DEPO)
  • Inyx, Inc. (IYXI)
Target (Total: 7)
  • Johnson & Johnson (JNJ)
  • Pfizer Inc. (PFE)
  • Novartis AG (ADR) (NVS)
  • Tyco International Ltd. (TYC)
Buyer (Total: 8)
  • McKesson Corporation (MCK)
  • AmerisourceBergen Corp. (ABC)
  • Cardinal Health, Inc. (CAH)
  • QLT Inc. (USA) (QLTI)
Target (Total: 4)
  • Tyco International Ltd. (TYC)
  • Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
  • Sciele Pharma Inc. (SCRX)
  • Impax Laboratories Inc. (IPXL)

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 2,795 1,680
Revenue Per Employee 715,739.5 608,216.4
Total Revenue 499.6 254.8
Total Expenses 335.0 257.1
Other Revenue 0.0 0.0
Cost of Revenue 107.0 203.1
SG&A Expense 154.2 41.0
Research & Development 34.6 13.0
Other Operating Expense 0.0 0.0
Operating Income 164.7 -2.4
Unusual Income 0.6 0.0
LT Debt to Capital 15.71 0
Fwd P/E 10.07 46.24
Fwd P/Rev 2.10 1.77
Book Value 2,146.6 771.9
Curr Portion of LTD/Cap Lease 4.3 0.0

Individual Company Summary

Focused

Buyer

Focused (): *Healthcare > Biopharmaceuticals

Target

Focused (): *Healthcare > Biopharmaceuticals

Business Description

Buyer

King Pharmaceuticals, Inc. (King) is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products. The Company operates through five segments: Branded pharmaceuticals, Meridian Medical Technologies, Royalties, Contract manufacturing and other. King's branded pharmaceutical products can be divided primarily into six therapeutic areas: cardiovascular/ metabolic (including Altace, Corgard, Levoxyl and Cytomel); neuroscience (including Sonata and Skelaxin), hospital/ acute care (including Thrombin-JMI, Bicillin, Synercid and Intal), and other. Meridian Medical Technologies segment consists of its auto-injector business, which includes EpiPen. In March 2006, the Company acquired the rights to market and sell EpiPen throughout Canada until 2015. In addition, the Company manufactures pharmaceutical products under contracts with a variety of pharmaceutical and biotechnology companies.

Target

Andrx Corporation is a pharmaceutical company that operates in four segments. The Distributed Products segment distributes primarily generic pharmaceuticals manufactured largely by others, as well as by Andrx, from its Weston, Florida and Groveport, Ohio distribution facilities. Through the Generic Products segment, the Company researches, develops, manufactures and sells generic versions of selected controlled-release pharmaceuticals, utilizing its drug delivery technologies, as well as generic versions of immediate-release and oral contraceptive products, primarily to a limited number of large pharmaceutical wholesalers and warehousing pharmacy chains. Through the Brand Products segment, the Company develops and commercializes brand name pharmaceuticals, in many cases, using its controlled-release drug delivery technologies. The Contract Services segment is pursuing the development and manufacture of pharmaceutical products for other pharmaceutical companies.

Deal Summary

Key Ratios

  Buyer Target
Gross Margin % 81.35 21.01
Operating Margin % 14.42 -0.23
Quick Ratio 1.74 2.15
Current Ratio 2.34 3.79
Coverage Ratio 0.05 -7.61
Total Assets 3,179.8 1,120.2
Return on Equity % 8.86 1.11
Return on Assets % 5.98 0.76
Cash+ ST Inv. Per Share 3.31 4.15
Total Debt 404.3 0.0
Total Debt to Equity % 18.83 0
Total Debt to Tangible Equity % 37.49 0
Debt to Asset % 12.71 0.00

Product Summary

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
Dermatology
The Dermatology Subsector includes therapeutics that treat disorders affecting the skin.
  
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
Endocrinology/Metabolism
The Endocrinology/Metabolism Subsector includes therapeutics that treat metabolic disorders and conditions resulting from the dysfunction of hormone secreting glands.
Hematology
The Hematology Subsector includes therapeutics that treat blood-based diseases and disorders.
  
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
  
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
Obstetrics/Gynecology
The Obstetrics/Gynecology Subsector includes therapeutics that treat female genital disorders, pregnancy, and childbirth.
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
  
Ophthalmology
The Ophthalmology Subsector includes therapeutics that treat eye disorders, infections, inflammations and irritations.
  
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
  
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
  
Wound Management
The Wound Management Subsector includes therapeutics that treat cuts, abrasions, and burns from trauma or diseases.
  
Healthcare Services  
Distributors
The Distributors Subsector is comprised of companies that distribute a wide variety of healthcare products, equipment and supplies to healthcare service providers and institutions.
  
Medical Devices  
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
  
Clinical Diagnostics
The Clinical Diagnostics Subsector includes medical devices that analyze human body specimens within a medical setting. These devices, including equipment, biological and chemical reagents are primarily used for the diagnosis of diseases.
  
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
  
Radiology
The Radiology Subsector includes medical devices that generate images of internal physiology.
  
Nutritional Health  
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
  
Outsourced Services
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
Drug Delivery Technology
The Drug Delivery Technology Subsector includes companies that develop novel delivery methods for therapeutics.
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies
Systemic  
Anaphylactic Shock  
Alpha Adrenergic Receptor Agonists/Beta Adrenergic Receptor Agonists
Therapeutics that treat allergic shock by stimulating alpha and beta adrenergic receptors.

Buyer Products:

  • Adrenalin Chloride Solution (Epinephrine)
  
Upper Respiratory  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Target Products:

  • Andrx Pharmaceuticals Loratadine Rapidly-Disintegrating Tablet
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Target Products:

  • Andrx Pharmaceuticals Loratadine/Pseudoephedrine Sulfate
  • Andrx Pharmaceuticals Loratadine/Pseudoephedrine Extended Release
  
Cardiovascular System
Heart Disorders
Angina
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Corgard (Nadolol)

Target Products:

  • Andrx Pharmaceuticals Metoprolol Succinate
Calcium Channel Blocking Agents
Therapeutics that treat chest pains by preventing the entry of calcium into heart muscle cells.

Target Products:

  • Andrx Pharmaceuticals Diltia XT (Diltiazem HCl Extended-Release)
  • Andrx Pharmaceuticals Taztia (Diltiazem HCl)
  • Andrx Pharmaceuticals Cartia XT (Diltiazem HCl Extended-Release)
  • Andrx Pharmaceuticals Taztia XT (Diltiazem HCl Extended Release)
  
Arrhythmia  
Adenosine A1 Receptor Agonists
Therapeutics that treat abnormal rhythm of the heart beat by selectively stimulating the A1 adenosine receptor, slowing the speed of AV nodal conduction

Buyer Products:

  • Adenocard (Adenosine)
  
Sodium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of sodium into heart muscle cells.

Buyer Products:

  • Procanbid (Procainamide Hydrochloride)
  
Heart Failure (HF)
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat the ineffective pumping of the heart by inhibiting the renin-angiotensin system.

Buyer Products:

  • Altace (Ramipril)

Target Products:

  • Andrx Pharmaceuticals Monopril (Fosinopril Sodium)
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat the ineffective pumping of the heart by blocking beta adrenergic receptors of the heart muscle.

Target Products:

  • Andrx Pharmaceuticals Metoprolol Succinate
  
Complications  
Edema  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Vascular Disorders
Atherosclerosis  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that treat the narrowing or hardening of the arteries by preventing the synthesis of cholesterol.

Target Products:

  • Andrx Pharmaceuticals Lovastatin
  
Hypertension
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat high blood pressure by inhibiting the renin-angiotensin system.

Buyer Products:

  • Altace (Ramipril)

Target Products:

  • Andrx Pharmaceuticals Quinapril Hydrochloride
  • Andrx Pharmaceuticals Benazepril Hydrochloride
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by inhibiting the renin-angiotensin system and increasing the excretion of sodium ions, potassium ions, and water through urine.

Target Products:

  • Andrx Pharmaceuticals Benazepril Hydrochloride/Hydrochlorothiazide
  • Andrx Pharmaceuticals Fosinopril Sodium/Hydrochlorothiazide
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Corgard (Nadolol)

Target Products:

  • Andrx Pharmaceuticals Metoprolol Succinate
Beta Receptor Blocking Agents (Beta Blockers)/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle and increasing the excretion of sodium ions, potassium ions, and water through urine.

Buyer Products:

  • Corzide (Nadolol/Bendroflumethiazide)
  
Calcium Channel Blocking Agents
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle and increasing the excretion of sodium ions, potassium ions, and water through urine.

Target Products:

  • Andrx Pharmaceuticals Diltia XT (Diltiazem HCl Extended-Release)
  • Andrx Pharmaceuticals Cartia XT (Diltiazem HCl Extended-Release)
  • Andrx Pharmaceuticals Taztia (Diltiazem HCl)
  
Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Peripheral Vascular Disease  
Blood Viscosity Reducing Agents
Therapeutics that treat arterial obstruction outside of the heart by altering the flow of red blood cells.

Target Products:

  • Andrx Pharmaceuticals Cilostazol
  
Dermatology  
Lesion/Scaling Disorders  
Dermatoses  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotic)
Therapeutics that counteract or suppress inflammation by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site, as well as prevent the growth of bacteria.

Buyer Products:

  • Cortisporin (Neomycin/Polymyxin B Sulfates/Hydrocortisone Acetate) Cream/Ointment
  
Digestive System
Gastrointestinal Tract Disorders
Gastroduodenal Disorders  
Peptic Ulcers  
Duodenal  
H2 Receptor Antagonists
Therapeutics that treat peptic ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Famotidine Tablets USP
  
Proton Pump Inhibitors
Therapeutics that treat peptic ulcers by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Omeprazole
  
Gastric  
H2 Receptor Antagonists
Therapeutics that treat peptic ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Famotidine Tablets USP
  
Proton Pump Inhibitors
Therapeutics that treat peptic ulcers by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Omeprazole
  
Zollinger-Ellison Syndrome  
H2 Receptor Antagonists
Therapeutics that treat ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Famotidine Tablets USP
  
Proton Pump Inhibitors
Therapeutics that treat ulcers by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Omeprazole
  
Gastroesophageal Disorders
Acid Indigestion/Heartburn  
H2 Receptor Antagonists
Therapeutics that treat indigestion by blocking the action of histamine at the H2 receptors.

Target Products:

  • Andrx Pharmaceuticals Famotidine Tablets USP
  
Erosive Esophagitis  
Proton Pump Inhibitors
Therapeutics that treat Erosive Esophagus by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Omeprazole
  
Gastroesophageal Reflux Disease (GERD)  
H2 Receptor Antagonists
Therapeutics that treat Gastroesophageal Reflux Disease by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Famotidine Tablets USP
  
Proton Pump Inhibitors
Therapeutics that treat Gastroesophageal Reflux Disease by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.

Target Products:

  • Andrx Pharmaceuticals Omeprazole
  
Nausea/Vomiting  
Antiemetic Agents
Therapeutics that treat nausea or vomiting by acting locally on the hyperactive gastrointestinal wall.

Buyer Products:

  • Tigan (Trimethobenzamide Hydrochloride)
  
Liver Disorders  
Cirrhosis  
Complications  
Edema  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Endocrinology/Metabolism
Adrenal Gland Disorders  
Adrenocortical Insufficiency  
Synthetic Adrenocortical Steroids
Therapeutics that treat Adrenocortical Insufficiency by acting on the distal tubules of the kidney to enhance the reabsorption of sodium ions and to increase the urinary excretion of both potassium and hydrogen ions.

Buyer Products:

  • Florinef (Fludrocortisone Acetate)
  
Diabetes
Induced Complications  
Central Diabetes Insipidus  
Antidiuretic Agents
Therapeutics that treat prevent the lose of water in the urine.

Buyer Products:

  • Pitressin (Vasopressin)
  
Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes  
Biguanides
Therapeutics that treat abnormally high blood glucose levels by decreasing the production of glucose in the liver, decreasing intestinal absorption of glucose and increasing peripheral uptake and utilization of glucose.

Target Products:

  • Andrx Pharmaceuticals Metformin Hydrochloride Extended Release
  • Andrx Pharmaceuticals Metformin Hydrochloride
  
Biguanides/Peroxisome Proliferator-Activated Receptor Agonists (PPAR Agonists)
Therapeutics that control high blood sugar by stimulating the release of insulin as well as sensitizing organs to insulin.

Target Products:

  • Andrx Laboratories ACTOplus met XR (Pioglitazone/Metformin Extended Release)
  
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that treat non-insulin dependent diabetes by stimulating the secretion of insulin.

Target Products:

  • Andrx Pharmaceuticals Glipizide Extended Release
  
General Hormone Treatments  
Estrogens
Therapeutics that treat hormonal disorders by providing estrogen.

Buyer Products:

  • Delestrogen (Estradiol Valerate Injection, USP)
  • Menest (Esterified Estrogens Tablets)
  
Hyperglycemia  
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that stimulate the secretion of insulin.

Target Products:

  • Andrx Pharmaceuticals Glipizide Extended Release
  
Intermediary Metabolism Disorders  
Gout  
Gouty Arthritis  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that counteract or suppress inflammation preventing cyclooxygenase activity.

Target Products:

  • Andrx Pharmaceuticals Naproxen Sodium
  
Hypercholesterolemia  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.

Target Products:

  • Andrx Pharmaceuticals Lovastatin
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • MRE0094 (Adenosine A2a Receptor Agonist)
  
Pituitary Gland Disorders  
Pituitary Hyperthyroidism (TSH-Induced)  
Thyroid Hormones
Hormones that affect the rate of cell metabolism and blood calcium levels.

Buyer Products:

  • Levoxyl (Levothyroxine Sodium)
  
Reproductive Disorders  
Hypogonadism  
Female  
Hormonal Treatments  
Estrogens
Therapeutics that are female sex hormones.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)
  
Menopause  
Estrogens
Therapeutics that are female sex hormones.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)
  
Thyroid Gland Disorders  
Hyperthyroidism  
Thyroid Hormone Synthesis Inhibitors
Therapeutics that stop the production of thyroid hormones.

Buyer Products:

  • Tapazole (Methimazole)
  
Hypothyroidism  
Thyroid Hormones
Therapeutics that treat a deficiency in thyroid activity by supplementing thyroid hormones.

Buyer Products:

  • Levoxyl (Levothyroxine Sodium)
  • Triostat (Liothyronine Sodium)
  • Cytomel (Liothyronine Sodium)
  
Hematology  
Serum Factor Disorders  
Hypercholesterolemia  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.

Target Products:

  • Andrx Pharmaceuticals Lovastatin
  
Hyperglycemia  
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that stimulate the secretion of insulin.

Target Products:

  • Andrx Pharmaceuticals Glipizide Extended Release
  
Hypokalemia  
Potassium Supplements
Therapeutics that treat hypokalemia by providing potassium to the body.

Target Products:

  • Andrx Pharmaceuticals Potassium Chloride Extended Release
  
Immunology  
Autoimmune Disorders  
Arthritis  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Target Products:

  • Andrx Pharmaceuticals Ketoprofen Extended Release
  • Andrx Pharmaceuticals Naproxen Sodium
  • Andrx Pharmaceuticals Etodolac Extended Release
  
Infectious Diseases
Bacterial
Antibacterial Agents
Broad Spectrum
Antibiotics
Aminoglycosides
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis.

Buyer Products:

  • Coly-Mycin M Parenteral (Colistimethate Sodium)
  
Carbacephems
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.

Buyer Products:

  • Lorabid (Loracarbef)
  
Macrolides
Therapeutics that treat a wide variety of infections by inhibiting RNA-dependent bacterial protein synthesis.

Target Products:

  • Andrx Pharmaceuticals Clarithromycin Extended Release
  
Penicillin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis during active multiplication.

Buyer Products:

  • Bicillin C-R/C-R 900/300/C-R Pediatric (Penicillin G Benzathine/Penicillin G Procaine Injectable Suspension)
  • Bicillin L-A/L-A Pediatric (Penicillin G Benzathine Injectable Suspension)
  • Penicillin G Procaine Injectable Suspension
  
Quinolones/Fluoroquinolones
Therapeutics that treat a wide variety of infections by promoting breakage of bacterial DNA strands.

Buyer Products:

  • Synercid (Quinupristin/Dalfopristin)
  
Narrow Spectrum  
Dermatology  
Dermatoses  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotics)
Therapeutics that treat bacterial infections of the skin with a steroidal compound and a compound that kills or inhibits the growth of bacteria.

Buyer Products:

  • Cortisporin (Neomycin/Polymyxin B Sulfates/Hydrocortisone Acetate) Cream/Ointment
  
Skin/Soft Tissue Infections  
Sulfonamides
Therapeutics that treat specific bacterial infections by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Musculoskeletal System  
Skin/Soft Tissue Infections  
Sulfonamides
Therapeutics that treat bacterial infections of non-skeletal tissue usually involving fat, muscle, and skin by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Ophthalmology  
Ocular Infections  
Aminoglycosides/Polypeptides
Therapeutics that treat bacterial infections of the eye by inhibiting bacterial protein synthesis and damaging the cell membrane.

Buyer Products:

  • Neosporin Ophthalmic (Neomycin Sulfate B/Polymyxin Sulfate B/Gramicidin) Ointment/Solution Sterile
  
Aminoglycosides/Polypeptides/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat bacterial infections of the eye by inhibiting bacterial protein synthesis, damaging the cell membrane, and suppressing the full immune response.

Buyer Products:

  • Cortisporin Opthalmic (Neomycin/Polymyxin B Sulfates/Bacitracin Zinc/Hydrocortisone) Ointment/Suspension Sterile
  
Polypeptides
Therapeutics that treat bacterial infections of the eye by damaging the cell membrane.

Buyer Products:

  • Polysporin (Bacitracin Zinc/Polymyxin B Sulfate)
  
Otolaryngology (Ear/Nose/Throat)  
External Ear Canal Infections  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotic)
Therapeutics that treat bacterial infections of the external auditory canal with a steroidal compound and by killing or inhibiting the growth of microorganisms.

Buyer Products:

  • Cortisporin-TC Otic (Colistin Sulfate/Neomycin Sulfate/Thonzonium Bromide/Hydrocortisone Acetate)
  • Cortisporin Otic (Neomycin/Polymyxin B Sulfate/Hydrocortisone) Solution/Suspension Sterile
  • Coly-Mycin S Otic (Colistin Sulfate/Neomycin Sulfate/Thonzonium Bromide/Hydrocortisone Acetate)
  • Pediotic Suspension Sterile (Neomycin/Polymyxin B Sulfates/Hydrocortisone)
  
Otitis Media  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the middle ear inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Respiratory System  
Bronchitis  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the bronchi in the lungs by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Pneumonia  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat inflammation of the lungs caused by bacterial infection by inhibiting folic acid synthesis and bacterial growth.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Urology  
Urinary Tract Infections (UTI)  
Antibacterial Agents (Antibiotics)  
Aminoglycosides
Therapeutics that treat bacterial infections of the urethra, urinary bladder, ureters, and kidneys by inhibiting bacterial protein synthesis.

Buyer Products:

  • Neosporin G.U. Irrigant (Neomycin Sulfate/Polymyxin B Sulfate)
  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections of the urinary tract by inhibiting dihydrofolate reductase resulting in decreased bacterial nucleic acid/protein production.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Trimethoprim
Therapeutics that treat bacterial infections of the urethra, urinary bladder, ureters, and kidneys by blocking the action of bacterial dihydrofolate reductase.

Buyer Products:

  • Proloprim (Trimethoprim) Tablets
  
Mycological (Fungal)  
Antifungal Agents  
Narrow Spectrum  
Dermatology  
Onychomycosis (Nail)  
Amine Derivatives  
Allyl
Therapeutics that treat fungal infections of the nail caused by yeast by causing a deficiency in the cell wall.

Target Products:

  • Andrx Pharmaceuticals Terbinafine Hydrochloride
  
Protozoal  
Antiprotozoal Agents  
Narrow Spectrum  
Amebiasis  
Aminoglycosides
Therapeutics that treat infections by an amoeba by inhibiting protozoal protein synthesis.

Buyer Products:

  • Humatin (Paramomycin Sulfate)
  
Viral  
DNA Viruses  
Herpesvirus  
Herpes Simplex Type 1  
Viral DNA Polymerase Inhibitors
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA blocking the action of an essential enzyme.

Buyer Products:

  • Viroptic Ophthalmic Solution (Trifluridine)
  
Herpes Simplex Type 2  
Viral DNA Polymerase Inhibitors
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by blocking the action of an essential enzyme.

Buyer Products:

  • Viroptic Ophthalmic Solution (Trifluridine)
  
Musculoskeletal System
Skeletal Disorders
Bone Disorders  
Osteoporosis  
Hormonal Treatments  
Estrogens
Therapeutics that treat osteoporosis by providing female hormones which results in a decrease in the rate of bone loss due to osteoclasts.

Buyer Products:

  • Delestrogen (Estradiol Valerate Injection, USP)
  
Joint Disorders  
Ankylosing Spondylitis  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.

Target Products:

  • Andrx Pharmaceuticals Naproxen Sodium
  
Gouty Arthritis  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by inhibiting cyclooxygenase activity.

Target Products:

  • Andrx Pharmaceuticals Naproxen Sodium
  
Osteoarthritis (OA)  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.

Target Products:

  • Andrx Pharmaceuticals Naproxen Sodium
  • Andrx Pharmaceuticals Ketoprofen Extended Release
  • Andrx Pharmaceuticals Etodolac Extended Release
  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Target Products:

  • Andrx Pharmaceuticals Etodolac Extended Release
  • Andrx Pharmaceuticals Ketoprofen Extended Release
  • Andrx Pharmaceuticals Naproxen Sodium
  
Neurology
Neurological Disorders
Epilepsy
Partial Seizures  
Complex  
Adjunctive Therapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat complex partial seizures by preventing the uptake of gamma-aminobutyric acid, which prevent nerve activation.

Target Products:

  • Andrx Laboratories Valproate Delayed Release Tablet (Divalproex)
  • Andrx Pharmaceuticals Gabapentin
  
Monotherapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat complex partial seizures by preventing the uptake of gamma-aminobutyric acid, that prevents nerve activation.

Target Products:

  • Andrx Laboratories Valproate Delayed Release Tablet (Divalproex)
  
Primary Generalized Seizures  
Absence (Petit Mal)  
Adjunctive Therapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Petit Mal Seizures by preventing the uptake of molecules that prevents nerve activation.

Target Products:

  • Andrx Laboratories Valproate Delayed Release Tablet (Divalproex)
  
Monotherapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Petit Mal Seizures by preventing the uptake of molecules that prevents nerve activation.

Target Products:

  • Andrx Laboratories Valproate Delayed Release Tablet (Divalproex)
  
Status Epilepticus  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat status epilepticus by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Vanquix (Diazepam Auto-Injection)
  
Headaches  
Vascular (Migraine)  
Prophylactic Treatments  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that provide preventative treatments for migraine headaches by inhibiting the uptake of molecules that prevent nerve activation.

Target Products:

  • Andrx Laboratories Valproate Delayed Release Tablet (Divalproex)
  
Neuromuscular Disorders  
Parkinson`s Disease (PD)  
Adjunctive Treatments  
Cholinergic Receptor Blocking Agents
Therapeutics that assist in the treatment of the disorder involving nerve cell loss in portions of the brain that leads to uncontrolled tremors, abnormal posture and speech problems by blocking acetylcholine receptors on neurons.

Buyer Products:

  • Kemadrin (Procyclidine Hydrochloride)
  
Psychiatric Disorders
Anxiety  
Generalized Anxiety Disorder (GAD)  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat anxiety by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Paroxetine Hydrochloride
  
Obsessive Compulsive Disorder (OCD)  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat Anxiety by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Sertraline Hydrochloride
  • Andrx Pharmaceuticals Paroxetine Hydrochloride
  • Andrx Pharmaceuticals Fluoxetine Hydrochloride
  
Panic Disorder  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat panic disorder by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Sertraline Hydrochloride
  • Andrx Pharmaceuticals Paroxetine Hydrochloride
  
Post-Traumatic Stress Disorder (PTSD)  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat post traumatic stress disorder by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Sertraline Hydrochloride
  • Andrx Pharmaceuticals Paroxetine Hydrochloride
  
Social Anxiety Disorder (SAD)  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat Social Anxiety Disorder by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Sertraline Hydrochloride
  • Andrx Pharmaceuticals Paroxetine Hydrochloride
  
Childhood/Adolescent Disorders  
Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD)  
Dopamine Receptor Blocking Agents
Therapeutics that treat attention deficit disorder by blocking the dopamine receptors.

Target Products:

  • Andrx Pharmaceuticals Methylphenidate Hydrochloride
  
Eating Disorders  
Bulimia  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat eating disorders by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Fluoxetine Hydrochloride
  
Mood Disorders  
Bipolar Disorders (Manic Depressive Disorders)  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat bipolar disorders by preventing the uptake of gamma-aminobutyric acid, that prevents nerve activation.

Target Products:

  • Andrx Laboratories Valproate Delayed Release Tablet (Divalproex)
  
Depression  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat depression by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Paroxetine Hydrochloride
  • Andrx Pharmaceuticals Sertraline Hydrochloride
  • Andrx Pharmaceuticals Fluoxetine Hydrochloride
  
Tetracyclic Compounds
Therapeutics that treat depression by increasing the synaptic concentrations of norepinephrine.

Target Products:

  • Andrx Pharmaceuticals Mirtazapine
  
Premenstrual Dysphoric Disorders  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat premenstrual dysphoric disorders by selectively preventing the removal of serotonin.

Target Products:

  • Andrx Pharmaceuticals Sertraline Hydrochloride
  
Sleep Disorders  
Insomnia  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.

Buyer Products:

  • Sonata CIV (Zaleplon)
  
Obstetrics/Gynecology
Child Birth/Pregnancy
Induction/Cervical Ripening  
Oxytocic Agents
Therapeutics that induce contractions by increasing the levels of intracellular calcium in the uterine smooth muscle thus mimicking uterine contractions and transiently impeding uterine blood flow.

Buyer Products:

  • Pitocin (Oxytocin)
  
Prevention (Contraception)  
Contraceptives (Birth Control)  
Estrogens/Progestins
Therapeutics that prevent conception by decreasing the secretion of gonadotropin-releasing hormone in the hypothalamus, resulting in an anti-ovulatory effect.

Target Products:

  • Andrx Pharmaceuticals Previfem (Norgestimate/Ethinyl Estradiol)
  • Andrx Pharmaceuticals Tri-Previfem (Norgestimate/Ethinyl Estradiol)
  • Andrx Pharmaceuticals Norethindrone/Ethinyl Estradiol/Ferrous Fumarate
  
Female Genital Disorders  
Ovarian  
Hypogonadism  
Hormonal Treatments  
Estrogens
These are female sex hormones.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)
  • Delestrogen (Estradiol Valerate Injection, USP)
  
Vulvovaginal  
Atrophy  
Hormonal Treatments  
Estrogens
Therapeutics that treat disorders characterized by thinning of the vaginal walls with the female sex hormone estrogen.

Buyer Products:

  • Delestrogen (Estradiol Valerate Injection, USP)
  • Menest (Esterified Estrogens Tablets)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of female reproductive disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Bremelanotide/PT-141 (Alpha Melanocyte-Stimulating Hormone Analog)
  
Oncology  
Breast Cancer  
Palliative Agents  
Hormonal Treatments  
Estrogens
Therapeutics that treat and manage breast cancer in post-menopausal women by providing female hormones.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)
  
Urology  
Prostate Cancer  
Palliative Agents  
Estrogens
Therapeutics that treat and manage prostate cancer by inhibiting the secretion of luteinizing hormone and affecting the testes so as to decrease serum concentrations of testosterone but are not curative.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)
  
Ophthalmology  
Degenerative Disorders  
Irritation/Inflammation  
Antibacterial Agents (Antibiotics)
Therapeutics that treat infections by inhibiting bacterial replication.

Buyer Products:

  • Polysporin (Bacitracin Zinc/Polymyxin B Sulfate)
  • Neosporin Ophthalmic (Neomycin Sulfate B/Polymyxin Sulfate B/Gramicidin) Ointment/Solution Sterile
  
Antibacterial Agents/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat infections by inhibiting bacterial replication as well as prevent cells that cause inflammation from adhering to the inflammation site.

Buyer Products:

  • Cortisporin Opthalmic (Neomycin/Polymyxin B Sulfates/Bacitracin Zinc/Hydrocortisone) Ointment/Suspension Sterile
  
Pain Management
Anesthesia  
General (Systemic)  
Adjunctive  
Acetylcholine Blocking Agents
Therapeutics that inhibit neuromuscular activity by competing with acetylcholine at the cholinergic receptors resulting in neuromuscular blockage.

Buyer Products:

  • Ketalar CIII (Ketamine Hydrochloride)
  
Barbiturates
Therapeutics that result in anesthesia due to a general sedative effect by enhancing the response to gamma aminobutyric acid and decrease excitability by directly suppressing conduction in the brain.

Buyer Products:

  • Brevital Sodium C-IV (Methohexital Sodium)
  
Primary  
Barbiturates
Therapeutics that result in anesthesia due to a general sedative effect by enhancing the response to gamma aminobutyric acid and decrease excitability by directly suppressing conduction in the brain.

Buyer Products:

  • Brevital Sodium C-IV (Methohexital Sodium)
  
Narcotics
Analgesics/Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.

Target Products:

  • Anexsia (Acetaminophen/Hydrocodone Bitartrate)
  • Andrx Pharmaceuticals Codeine Phosphate/Acetaminophen
  • Andrx Pharmaceuticals Ibuprofen/Hydrocodone Bitartrate
  • Andrx Pharmaceuticals Propoxyphene Hydrochloride/Acetaminophen
  • Andrx Pharmaceuticals Acetaminophen/Tramadol Hydrochloride
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Remoxy (Time-Release Oxycodone)
  • Avinza (Morphine Sulfate ER Capsules)

Target Products:

  • Andrx Pharmaceuticals Fentanyl
  • Andrx Pharmaceuticals Oxycodone HCl Extended Release
Non-Narcotics
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain by non-specifically inhibiting the action of cyclooxygenase.

Target Products:

  • Andrx Pharmaceuticals Naproxen Sodium
  
Skeletal Muscle Relaxing Agents
Therapeutics that treat pain by depressing specific synaptic reflexes preferentially.

Buyer Products:

  • Skelaxin (Metaxalone)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of pain in early stages of clinical research where human subject is involved.

Buyer Products:

  • PTI-202
  • T-62
  
Respiratory System
Lower Respiratory Tract Disorders (Lung Disorders)
Asthma
Acute Treatments
Bronchodilators
Alpha Adrenergic Receptor Agonists/Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Buyer Products:

  • Adrenalin Chloride Solution (Epinephrine)
  
Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Target Products:

  • Armstrong Pharmaceuticals Albuterol MDI
  • Andrx Pharmaceuticals Albuterol Inhalation Aerosol
  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in dilating the blood vessels in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Prophylactic Treatments  
Mast Cell Stabilizers
Therapeutics that treat asthma by inhibiting mast cell degranulation.

Buyer Products:

  • Intal HFA (Cromolyn Sodium)
  • Tilade (Nedocromil Sodium)
  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in relaxing smooth muscles in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Bronchitis
Acute Treatments  
Bronchodilators  
Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Target Products:

  • Armstrong Pharmaceuticals Albuterol MDI
  • Andrx Pharmaceuticals Albuterol Inhalation Aerosol
  
Complications  
Bacterial Infections  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Prophylactic Treatments  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in relaxing smooth muscles in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Bronchospasm
Bronchodilators
Alpha Adrenergic Receptor Agonists/Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Buyer Products:

  • Adrenalin Chloride Solution (Epinephrine)
  
Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Target Products:

  • Armstrong Pharmaceuticals Albuterol MDI
  • Andrx Pharmaceuticals Albuterol Inhalation Aerosol
  
Chronic Obstructive Pulmonary Disease (COPD)  
Acute Treatments  
Bronchodilators  
Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Target Products:

  • Andrx Pharmaceuticals Albuterol Inhalation Aerosol
  • Armstrong Pharmaceuticals Albuterol MDI
  
Emphysema  
Prophylactic Treatments  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in relaxing smooth muscles in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Upper Respiratory Tract Disorders
Coughs/Colds
Anticholinergic Agents/Opioids
Therapeutics that treat coughs and colds by relieving pain and fever as well as suppressing cough.

Buyer Products:

  • Tussigon Tablets CIII (Hydrocodone Bitartrate/Homatropine Methylbromide)
  
Decongestants/Antitussives
Therapeutics that treat coughs and colds by reducing mucous build up and suppressing the cough.

Buyer Products:

  • Nucofed Capsules/Syrup CIII (Codeine Phosphate/Pseudoephedrine Hydrochloride)
  
Decongestants/Antitussives/Expectorants
Therapeutics that treat coughs and colds by reducing mucous build up, suppressing coughs and helping in the ejection of the mucous.

Buyer Products:

  • Nucofed Expectorant/Pediatric Expectorant (Codeine Phosphate/Pseudoephedrine Hydrochloride/Guaifenesin)
  
Decongestants/Expectorants
Therapeutics that treat coughs and colds by reducing mucous build up and help in ejection of mucous.

Target Products:

  • Andrx Laboratories Entex LA (Phenylephrine Hydrochloride/Guaifenesin)
  • Andrx Laboratories Pseudoephedrine Extended Release/Guaifenesin Capsules
  • Andrx Pharmaceuticals Phenylephrine Hydrochloride/Guaifenesin
  
Surgery  
General  
Hemorrhage  
Coagulating Agents (Coagulants)
Therapeutics that treat bleeding during a surgical procedure by promoting blood clotting.

Buyer Products:

  • Thrombin JMI
  
Toxicology
Chemical Poisoning  
Nerve Gas  
Anticholinergic Agents
Therapeutics that treat toxicity due to nerve agent/gas by antagonizing the muscarine-like actions of acetylcholine and other choline esters.

Buyer Products:

  • AtroPen (Atropine)
  • Meridian Medical Technologies Duodote (Atropine/Pralidoxime Chloride Injection)
  
Substance Abuse  
Withdrawal  
Nicotine (Smoking Cessation)  
Serotonin/Norepinephrine Reuptake Inhibitors
Therapeutics that increase the concentration of several neurotransmitters in the brain by inhibiting their uptake.

Target Products:

  • Andrx Pharmaceuticals Bupropion Hydrochloride
  
Urology  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of urological disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Bremelanotide/PT-141 (Alpha Melanocyte-Stimulating Hormone Analog)
  
Urological Disorders  
Kidney (Renal)  
Chronic Renal Failure (CRF)  
Complications  
Edema  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Renal Insufficiency  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that delay or treat kidney disease by inhibiting the renin-angiotensin system.

Buyer Products:

  • Altace (Ramipril)
  
Wound Management  
Burns  
Complications  
Infections  
Antibacterial Agents (Antibiotics)  
Sulfonamides
Therapeutics that treat bacterial infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Antifungal Agents  
Sulfonamides
Therapeutics that treat fungal infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Healthcare Services  
Distributors  
Pharmaceutical  
Specialty/Generic
Specialty drug distributors focus on the distribution of specific drugs. Because specialty drug distributors typically target certain therapeutic areas, in addition to distributing only certain classes of drugs, these companies will provide complementary services to the targeted patient populations. Examples of such complementary services include disease management programs, drug therapies (such as infusion therapy), and other disease class-specific services.

Target Products:

  • Anda, Inc.
  • Value In Pharmaceuticals (VIP)/Valmed Pharmaceuticals
  
Medical Devices  
Cardiology  
Diagnostic  
Monitoring  
Monitors  
Electrocardiogram (ECG/EKG)  
Interpretive/Analysis
Specialized electrocardiogram devices that facilitate certain diagnostic functions and analysis.

Buyer Products:

  • Meridian Medical Technologies Prime ECG Electrocardiac Mapping System
  
Stress/Exercise Test
Instruments used to evaluate the cardiopulmonary system during exercise.

Buyer Products:

  • Binodenoson
  
Telemetry  
Telemetry Systems
Complete systems or devices used to facilitate transfer of vitals monitoring data from the patient's site to a central monitor.

Buyer Products:

  • Meridian Medical Technologies Transtelephonic Blood Pressure Monitors
  • Meridian Medical Technologies CardioBeepers
  
Clinical Diagnostics  
Immunoassays  
Reagents  
Test Kits  
Bacterial  
Tuberculosis
Immunoassay test kits which quantitatively measure tuberculosis antibody in plasma or serum.

Buyer Products:

  • Aplisol (Tuberculin Purified Protein Derivative)
  
Drug Delivery  
Percutaneous (Subcutaneous/Intramuscular/Intravenous)  
Automatic Injectors
Pen-shaped medical devices used to contain and deliver liquid medications to a specified needle depth with a press of a button.

Buyer Products:

  • Meridian Medical Technologies Auto-Injector Technology
  
Radiology  
Nuclear  
Gamma Camera  
Contrast Agents  
Radionuclides  
Adjuncts
Radioactive materials that are introduced to the body for nuclear imaging purposes.

Buyer Products:

  • Adenoscan
 
Nutritional Health  
Dietary/Naturopathic Supplements  
Women`s Health
Products consisting of dietary/naturopathic supplements that are intended to support women's health.

Target Products:

  • Andrx Corp.
  
Outsourced Services
Development/Manufacturing Services
Chemistry Services
Outsourced companies that provide medicinal chemistry, organic synthesis, process research, cGMP synthesis, and analytical services to the biopharmaceutical industry.

Buyer Products:

  • Meridian Medical Technologies Contract Development Services
  
Contract Manufacturing Organizations (CMO)
Medical Devices
Contract Manufacturing Organizations that manufacture (and/or design, develop) medical devices and products for other organizations.

Buyer Products:

  • Meridian Medical Technologies Contract Manufacturing Services
  
Pharmaceuticals
Active/Intermediate Chemicals
Intermediate and active ingredient contract manufacturing organizations that produce large quantities of small molecule compounds for use in final dosage forms.

Buyer Products:

  • King Pharmaceuticals Contract Manufacturing Services
  • Meridian Medical Technologies Contract Manufacturing Services

Target Products:

  • Armstrong Pharmaceuticals, Inc.
Biologics
Active Ingredient Contract Manufacturing Organizations (CMO) that manufacture antibodies, proteins, and genetic materials.

Buyer Products:

  • King Pharmaceuticals Contract Manufacturing Services
  
Drug Delivery Technology  
Oral Delivery  
Hydrogel Based
Drug Delivery Technologies used to deliver drugs in a jelly like base.

Target Products:

  • Andrx Laboratories Granulated Modulating Hydrogel System (GMHS)
  • Andrx Laboratories Delayed Pulsatile Hydrogel System (DPHS)
  • Andrx Laboratories Directly Compressible Hydrogel System
  • Andrx Laboratories Pulsatile Hydrogel System
  • Andrx Laboratories Solubility Modulating Hydrogel System (SMHS)
  
Hydrogel Based/Polymer Coated
Drug Delivery Technologies used to deliver drugs in a jelly like base which are enclosed using a polymer matrix.

Target Products:

  • Andrx Laboratories Granulated Modulating Hydrogel System (GMHS)
  
Osmotic
Drug Delivery Technologies utilizing an osmotic mechanism for sustained release of the drugs.

Target Products:

  • Andrx Laboratories Single Composition Osmotic Tablet System (SCOT)
  • Andrx Laboratories Porous Tablet System (PORTAB)
  
Polymer Coated
Drug Delivery Technologies used to deliver drugs in a polymer based matrix to hold/enclose the drug.

Target Products:

  • Andrx Laboratories Pelletized Pulsatile Delivery System (PPDS)
  • Andrx Laboratories Stabilized Pellet Delivery System (SPDS)
  • Andrx Laboratories Stabilized Tablet Delivery System (STDS)
  • Andrx Laboratories Pelletized Tablet System (PELTAB)
  • Andrx Laboratories Modified Antihistamine/Decongestant Combination System (MACS)
  • Andrx Laboratories Pulsatile Enteric Coating System
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Impax Laboratories Inc. n/a 404.129 345.95 20.53 3.59 n/a 6.89
Buyer
  Pfizer Inc. n/a 193,588.019 15.34 13.15 4.01 4.08 n/a
GlaxoSmithKline plc (ADR) n/a 153,937.494 15.14 15.28 3.48 3.58 15.31
sanofi-aventis (ADR) n/a 113,109.418 29.80 13.07 3.03 3.16 n/a
Wyeth n/a 67,538.571 16.58 15.89 3.40 3.36 n/a
Bristol Myers Squibb Co. n/a 48,243.839 21.75 23.30 2.58 2.69 9.99
Forest Laboratories, Inc. n/a 15,039.797 20.64 18.31 4.73 4.68 n/a
Shire plc (ADR) n/a 9,331.710 33.50 32.46 5.29 5.19 10.85
Watson Pharmaceuticals, Inc. n/a 2,678.138 38.93 21.30 1.53 1.44 2.55
Biovail Corporation (USA) n/a 2,531.675 6.91 6.76 2.48 2.40 6.75
Medicis Pharmaceutical Corporation n/a 1,938.301 n/a 48.94 5.98 5.58 9.91
Cubist Pharmaceuticals, Inc. n/a 1,184.926 n/a 180.92 6.77 5.93 40.41
Sciele Pharma Inc. n/a 731.262 16.40 17.92 2.61 2.54 11.51
Impax Laboratories Inc. n/a 404.129 345.95 20.53 3.59 n/a 6.89
Omrix Biopharmaceuticals, Inc. n/a 294.145 35.38 16.58 6.77 5.05 7.99
Neurocrine Biosciences, Inc. n/a 292.332 n/a -3.47 2.72 12.47 0.90
Vanda Pharmaceuticals Inc. n/a 279.317 n/a -3.19 n/a 0.01 7.56
Target
  Cardinal Health, Inc. n/a 25,649.449 24.60 17.66 0.31 0.29 7.62
McKesson Corporation n/a 14,360.415 17.39 18.32 0.16 0.16 3.52
AmerisourceBergen Corp. n/a 9,155.055 19.57 18.89 0.15 0.15 2.21
Barr Pharmaceuticals, Inc. n/a 5,305.811 15.77 15.40 4.04 3.75 4.33
Flamel Technologies S.A. (ADR) n/a 656.234 n/a -19.18 30.53 22.37 n/a
Impax Laboratories Inc. n/a 404.129 345.95 20.53 3.59 n/a 6.89
Penwest Pharmaceuticals n/a 385.474 n/a -12.51 104.43 78.58 n/a
Elite Pharmaceuticals, Inc. n/a 42.470 n/a n/a 72.14 n/a 5.36

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  sanofi-aventis (ADR) n/a 113,109.418 29.80 13.07 3.03 3.16 n/a
Palatin Technologies, Inc. n/a 184.284 n/a n/a 9.33 n/a 10.07
DepoMed, Inc. n/a 177.959 n/a -5.35 23.68 12.60 n/a
Inyx, Inc. n/a n/a n/a n/a n/a n/a n/a
Target
  Johnson & Johnson n/a 198,345.736 17.92 18.16 3.80 3.73 n/a
Pfizer Inc. n/a 193,588.019 15.34 13.15 4.01 4.08 n/a
Novartis AG (ADR) n/a 142,847.934 20.82 19.72 3.95 3.90 3.70
Tyco International Ltd. n/a 58,346.115 17.17 16.12 1.50 1.44 12.41
Elan Corporation, plc (ADR) n/a 6,158.356 n/a -18.54 11.52 11.33 n/a
Amphastar Pharmaceuticals, Inc. n/a n/a n/a n/a n/a n/a n/a
Ranbaxy Laboratories Ltd. n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  McKesson Corporation 27.00% 14,360.415 17.39 18.32 0.16 0.16 3.52
AmerisourceBergen Corp. 14.00% 9,155.055 19.57 18.89 0.15 0.15 2.21
Cardinal Health, Inc. n/a 25,649.449 24.60 17.66 0.31 0.29 7.62
QLT Inc. (USA) n/a 627.672 n/a 26.28 3.36 3.64 1.94
Salix Pharmaceuticals Ltd n/a 612.466 n/a 19.64 3.30 2.95 3.75
Vascular Solutions, Inc. n/a 116.182 n/a -44.76 2.86 2.64 8.55
Government - United States n/a n/a n/a n/a n/a n/a n/a
Merck KGaA n/a n/a n/a n/a n/a n/a n/a
Target
  Tyco International Ltd. n/a 58,346.115 17.17 16.12 1.50 1.44 12.41
Teva Pharmaceutical Industries Ltd (ADR) n/a 24,586.134 475.54 14.50 3.75 2.88 n/a
Sciele Pharma Inc. n/a 731.262 16.40 17.92 2.61 2.54 11.51
Impax Laboratories Inc. n/a 404.129 345.95 20.53 3.59 n/a 6.89

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Merck KGaA n/a n/a n/a n/a n/a n/a n/a
Buyer
  sanofi-aventis (ADR) n/a 113,109.418 29.80 13.07 3.03 3.16 n/a
Wyeth n/a 67,538.571 16.58 15.89 3.40 3.36 n/a
Eli Lilly & Co. n/a 63,392.776 19.62 17.90 4.14 4.12 4.86
Barr Pharmaceuticals, Inc. n/a 5,305.811 15.77 15.40 4.04 3.75 4.33
Arrow International, Inc. n/a 1,580.762 28.22 22.39 3.28 2.92 3.01
QLT Inc. (USA) n/a 627.672 n/a 26.28 3.36 3.64 1.94
Salix Pharmaceuticals Ltd n/a 612.466 n/a 19.64 3.30 2.95 3.75
Pain Therapeutics, Inc. n/a 359.575 41.01 54.07 6.83 6.19 4.42
Palatin Technologies, Inc. n/a 184.284 n/a n/a 9.33 n/a 10.07
Target
  Johnson & Johnson n/a 198,345.736 17.92 18.16 3.80 3.73 n/a
Pfizer Inc. n/a 193,588.019 15.34 13.15 4.01 4.08 n/a
Novartis AG (ADR) n/a 142,847.934 20.82 19.72 3.95 3.90 3.70
Tyco International Ltd. n/a 58,346.115 17.17 16.12 1.50 1.44 12.41
Teva Pharmaceutical Industries Ltd (ADR) n/a 24,586.134 475.54 14.50 3.75 2.88 n/a
Elan Corporation, plc (ADR) n/a 6,158.356 n/a -18.54 11.52 11.33 n/a
Watson Pharmaceuticals, Inc. n/a 2,678.138 38.93 21.30 1.53 1.44 2.55
Perrigo Company n/a 1,564.196 20.57 18.87 1.13 1.09 4.53
Sciele Pharma Inc. n/a 731.262 16.40 17.92 2.61 2.54 11.51
Impax Laboratories Inc. n/a 404.129 345.95 20.53 3.59 n/a 6.89
Schwarz Pharma, Inc. n/a n/a n/a n/a n/a n/a n/a
Ranbaxy Laboratories Ltd. n/a n/a n/a n/a n/a n/a n/a
Amphastar Pharmaceuticals, Inc. n/a n/a n/a n/a n/a n/a n/a
InvaGen Inc. n/a n/a n/a n/a n/a n/a n/a
Merck KGaA n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 1,925.2 1,001.4 2,926.6
Other Revenue 0.0 0.0 0.0
Total Revenue 1,925.2 1,001.4 2,926.6
Cost of Revenue 359.0 791.0 1,150.0
SG&A Expense 657.1 163.0 820.2
Depreciation & Amortization 138.6 0.0 138.6
Research & Development 109.6 49.6 159.2
Interest Expense 0.0 0.0 0.0
Other Operating Expense -0.2 0.0 -0.2
Unusual Expense (Income) 383.5 0.0 383.5
Total Expenses 1,647.6 1,003.7 2,651.3
Operating Income 277.6 -2.3 275.4
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng 15.1 17.2 32.4
Other, Net -1.4 -1.2 -2.6
Income Before Taxes 291.3 13.8 305.1
Income Taxes 101.2 5.2 106.4
Income After Taxes 190.1 8.6 198.7
Net Income - Excl. Xord. Items 190.1 8.6 198.7
Discontinued Operations -1.3 0.0 -1.3
Accounting Change 0.0 0.7 0.7
Net Income - Incl. Xord. Items 188.9 9.3 198.1
Income Avail. to Common 188.9 9.3 198.1
Share Items
Basic Avg. Shares Outstanding 242.2 73.9 316.1
Basic EPS - Excl. Xord. Items 0.78 0.12 0.63
Basic EPS - Incl. Xord. Items 0.78 0.13 0.63
Full Dilution Adjustment 0.0 0.0 0.0
Fully Diluted Shares Outstanding 242.8 74.5 317.2
F.D. EPS - Excl. Xord. Items 0.78 0.12 0.63
F.D. EPS - Incl. Xord. Items 0.78 0.12 0.62
Balance Sheet
Assets
Cash and Equivalents 23.9 15.7 39.5
ST Investments 778.6 293.5 1,072.1
Accounts Receivable 263.0 149.7 412.7
Inventory 206.1 229.5 435.6
Prepayments and Advances 88.0 15.0 103.0
Other Current Assets 75.7 103.5 179.2
Current Assets 1,435.2 806.8 2,242.0
Accum D&A 0.0 0.0 0.0
PPE, Net 302.5 233.4 536.0
Goodwill & Intangibles 1,068.2 11.0 1,079.2
Long Term Investments 11.4 58.4 69.8
Other Assets 0.0 0.0 0.0
Other LT Assets 362.5 10.6 373.0
Total Assets 3,179.8 1,120.2 4,300.0
Liabilities
Accounts Payable 70.0 118.9 188.9
Payable/Accrued 0.0 0.0 0.0
Accrued Expenses 483.9 94.1 578.1
ST Debt 0.0 0.0 0.0
Curr Port of LTD & Cap Lease Oblg 4.3 0.0 4.3
Other (Current) Liabilities 55.8 0.0 55.8
Current Liab. 614.1 213.0 827.1
LT Debt 400.0 0.0 400.0
Total LT Debt 400.0 0.0 400.0
Deferred Taxes 0.0 30.2 30.2
Other LT Liab. 19.1 105.2 124.3
Total Liabilities 1,033.2 348.4 1,381.6
Shareholders Equity
Common Stock 1,230.3 0.1 1,230.3
Additional Paid in Capital 0.0 522.5 522.5
Retained Earnings 916.5 250.5 1,167.0
Other Equity -0.2 -1.1 -1.4
Total Equity 2,146.6 771.9 2,918.4
Total Liab. & Equity 3,179.8 1,120.2 4,300.0
Shares Outstanding 243.1 73.9 317.0
Cash Flow
Operating Cash Flow
CF Net Income 0.0 9.3 9.3
CF Depreciation 0.0 36.0 36.0
CF Deferred Taxes 0.0 -5.6 -5.6
Other Non-Cash Items -1.2 28.7 27.5
Change in Working Capital 374.4 -35.4 339.0
Total Cash From Operating Activities 373.2 33.0 406.2
Investing Cash Flow (not calculated)
Capital Expenditures -96.5 -30.8 -127.2
Other Investing Cash Flows -338.7 -34.8 -373.6
Total Cash From Investing Activities -435.2 -65.6 -500.8
Financing Cash Flow (not calculated)
Dividends Paid 0.0 0.0 0.0
Purchase Or Sale of Stock 7.5 5.3 12.7
Purchase and Retirement of Debt 61.6 0.0 61.6
Other Financing Cash Flow -10.3 1.1 -9.2
Total Cash From Financing Activities 58.8 6.3 65.1
Exchange Rate Effects 0.0 0.0 0.0
Net Change in Cash -3.2 -26.3 -29.5
Cash Taxes Paid 107.2 6.0 113.2
Cash Interest Paid 10.6 1.2 11.8